SkillCell

SkillCell is a biotech company with the slogan "Biology-based, objective decision-making support tools". Founded in 2017, the company aims to revolutionize biochemical analysis for diagnostics by prioritizing patient ease of use. SkillCell has developed a CE-marked urine test for insulin-resistance identification (IDIR) and a CE-marked saliva test for Covid-19 (EasyCOV), both of which contribute to rapid and accessible diagnostics. The company's network includes global experts in multiple locations, and it has a strong public-private partnership with Sys2Diag, a CNRS laboratory. SkillCell's focus is on developing technologies to provide reliable answers, new choices, and opportunities for users' lives. They are committed to improving everyday lives and surroundings through their simplicity-centered approach. Currently, there is no public information available regarding the last investment and investors for SkillCell.